FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

410902002: Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3680868014 Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3680869018 Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2466353010 Moexipril hydrochloride 7.5mg/hydrochlorothiazide 12.5mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2472549010 Moexipril hydrochloride 7.5mg/hydrochlorothiazide 12.5mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3468944016 Product containing moexipril hydrochloride 7.5 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3486798010 Product containing moexipril hydrochloride 7.5 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501964016 Moexipril hydrochloride 7.5 mg and hydrochlorothiazide 12.5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3570017019 Product containing only moexipril hydrochloride 7.5 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3570018012 Product containing only moexipril hydrochloride 7.5 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3680868014 Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3680869018 Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3680870017 Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing hydrochlorothiazide and moexipril hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrochlorothiazide (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Moexipril hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Hydrochlorothiazide-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrochlorothiazide (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Hydrochlorothiazide (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value 12.5 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Moexipril hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Moexipril hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value 7.5 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Moexipril hydrochloride 7.5 mg oral tablet false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Hydrochlorothiazide (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Moexipril hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing hydrochlorothiazide and moexipril in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing only hydrochlorothiazide and moexipril in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Plays role Diuretic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Hydrochlorothiazide (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Hydrochlorothiazide (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Moexipril hydrochloride true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Moexipril hydrochloride true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start